ZA972971B - Method for gene transfer to the central nervous system. - Google Patents

Method for gene transfer to the central nervous system.

Info

Publication number
ZA972971B
ZA972971B ZA9702971A ZA972971A ZA972971B ZA 972971 B ZA972971 B ZA 972971B ZA 9702971 A ZA9702971 A ZA 9702971A ZA 972971 A ZA972971 A ZA 972971A ZA 972971 B ZA972971 B ZA 972971B
Authority
ZA
South Africa
Prior art keywords
cells
nervous system
central nervous
gene transfer
producer cells
Prior art date
Application number
ZA9702971A
Other languages
English (en)
Inventor
Bruce Cherksey
Louis R Bucalo
Original Assignee
Univ New York Medical Ct
Theracell Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ New York Medical Ct, Theracell Inc filed Critical Univ New York Medical Ct
Publication of ZA972971B publication Critical patent/ZA972971B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • A61K48/0075—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the delivery route, e.g. oral, subcutaneous
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C12N2510/02—Cells for production

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
ZA9702971A 1996-04-08 1997-04-08 Method for gene transfer to the central nervous system. ZA972971B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/629,308 US6210664B1 (en) 1996-04-08 1996-04-08 Method for gene transfer to the central nervous system

Publications (1)

Publication Number Publication Date
ZA972971B true ZA972971B (en) 1997-11-03

Family

ID=24522456

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9702971A ZA972971B (en) 1996-04-08 1997-04-08 Method for gene transfer to the central nervous system.

Country Status (13)

Country Link
US (2) US6210664B1 (es)
EP (1) EP0927043B8 (es)
JP (2) JP2000508641A (es)
AT (1) ATE347903T1 (es)
AU (1) AU724537C (es)
CA (1) CA2251232C (es)
DE (1) DE69737101T2 (es)
DK (1) DK0927043T3 (es)
ES (1) ES2277356T3 (es)
PT (1) PT927043E (es)
TW (1) TWI222870B (es)
WO (1) WO1997037684A1 (es)
ZA (1) ZA972971B (es)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6210664B1 (en) * 1996-04-08 2001-04-03 New York University Medical Center Method for gene transfer to the central nervous system
JP2009532369A (ja) * 2006-03-30 2009-09-10 リサーチ ファウンデーション オブ シティ ユニバーシティ オブ ニューヨーク 分泌性白血球プロテアーゼインヒビターによる神経再生の刺激
AU2019275406B2 (en) 2018-05-24 2024-11-14 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound
WO2019222856A1 (en) 2018-05-24 2019-11-28 Nureva Inc. Method, apparatus and computer-readable media to manage semi-constant (persistent) sound sources in microphone pickup/focus zones
WO2019226519A1 (en) 2018-05-24 2019-11-28 Celanese EVA Performance Polymers Corporation Implantable device for sustained release of a macromolecular drug compound
WO2022231930A1 (en) 2021-04-26 2022-11-03 Celanese Eva Performance Polymers Llc Implantable device for sustained release of a macromolecular drug compound

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3852823T2 (de) * 1987-09-11 1995-05-24 Hughes Howard Med Inst Transduktionsveränderte fibroblasten und ihre anwendung.
US5650148A (en) * 1988-12-15 1997-07-22 The Regents Of The University Of California Method of grafting genetically modified cells to treat defects, disease or damage of the central nervous system
EP0554352B1 (en) * 1990-10-19 2003-03-05 New York University A method for transplanting cells into the brain and therapeutic uses therefor
US5618531A (en) * 1990-10-19 1997-04-08 New York University Method for increasing the viability of cells which are administered to the brain or spinal cord
US5529774A (en) 1991-08-13 1996-06-25 The Regents Of The University Of California In vivo transfer of the HSV-TK gene implanted retroviral producer cells
JPH07503467A (ja) * 1992-01-23 1995-04-13 ニューヨーク ユニヴァーシティー 細胞を脳に移植する方法及びその治療使用
DE69431295T2 (de) * 1993-04-21 2003-05-15 Institut Pasteur, Paris Biokompatibles implantat zur in vivo expression und sekretion von therapeutischer verbindung
SG48813A1 (en) * 1993-08-12 1998-05-18 Cytotherapeutics Inc Improved composition and methods for the delivery of biologically active molecules using genetically altered cells contained in biocompatible immunoisolatory capsules
US5688773A (en) * 1994-08-17 1997-11-18 The General Hospital Corporation Method of selectively destroying neoplastic cells
US6210664B1 (en) * 1996-04-08 2001-04-03 New York University Medical Center Method for gene transfer to the central nervous system

Also Published As

Publication number Publication date
PT927043E (pt) 2007-03-30
CA2251232C (en) 2005-10-25
TWI222870B (en) 2004-11-01
DK0927043T3 (da) 2007-04-10
EP0927043A1 (en) 1999-07-07
US20010003585A1 (en) 2001-06-14
DE69737101D1 (de) 2007-01-25
DE69737101T2 (de) 2007-05-31
ATE347903T1 (de) 2007-01-15
AU724537C (en) 2001-07-19
US6565845B2 (en) 2003-05-20
EP0927043B8 (en) 2007-04-18
AU724537B2 (en) 2000-09-21
US6210664B1 (en) 2001-04-03
CA2251232A1 (en) 1997-10-16
EP0927043B1 (en) 2006-12-13
ES2277356T3 (es) 2007-07-01
EP0927043A4 (en) 2004-09-01
WO1997037684A1 (en) 1997-10-16
HK1021801A1 (en) 2000-07-07
JP2000508641A (ja) 2000-07-11
AU2444997A (en) 1997-10-29
JP2004337176A (ja) 2004-12-02

Similar Documents

Publication Publication Date Title
Devine Mesenchymal stem cells: will they have a role in the clinic?
Kim et al. Brain transplantation of human neural stem cells transduced with tyrosine hydroxylase and GTP cyclohydrolase 1 provides functional improvement in animal models of Parkinson disease
Heath Cells for tissue engineering
EP1007630A4 (en) NATURAL KILLER CELL LINES AND METHOD FOR USE
GR3036216T3 (en) Liver reserve cells.
CA2407505A1 (en) Hepatocyte lineage cells derived from pluripotent stem cells
AU2934197A (en) Isolation, propagation, and directed differentiation of stem cells from central nervous system of mammals
EP0953354A4 (en) HEMATOPOIETIC STEM CELLS PROLIFERING ACTIVE SUBSTANCES
NZ516236A (en) Altering life span of a recipient cell by transferring cell cytoplasm from a donor cell for use in gene therapy and cloning
IL87196A (en) Serum free medium for the growthof insect cells and expressionof products thereby
WO1997012960A3 (en) Solid support for use in cell cultivation, especially for the cultivation of liver cells, biological reactor containing said solid support and the use thereof in a bio-artificial liver system
SE0201328L (sv) Hematopoietisk differentiering av humana embryonala stamceller
CA2388811A1 (en) Techniques for growth and differentiation of human pluripotent stem cells
DE60020855D1 (de) Bedingte immortalisierung von zellen
Kasai et al. Cancer stem cells converted from pluripotent stem cells and the cancerous niche
DK1100936T3 (da) Fremgangsmåde til fremstilling af stresstolerante planter
Yoshida et al. Morphology and increased growth rate of atherosclerotic intimal smooth-muscle cells
AU2444997A (en) Method for gene transfer to the central nervous system
EP1666589A1 (en) Process for producing cytotoxic lymphocytes
IL137304A (en) Expanded and genetically modified populations of human hematopoietic stem cells
Glick et al. DNA-induced pigment production in a hamster cell line
ATE311466T1 (de) Menschliche pancreas zellinien: entwicklungen und anwendungen
Cossu et al. Similar glycopeptides in normal chondroblasts and in Rous sarcoma virus-transformed fibroblasts.
Karikusa et al. The restoration of the functions of serially passaged calf hepatocytes by spheroid formation
DE69737597D1 (de) Vektoren zur inhibierung von viralem und tumorwachstum